# Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone

> **NCT02603926** · PHASE2 · COMPLETED · sponsor: **Randi J. Hagerman, MD** · enrollment: 6 (actual)

## Conditions studied

- Fragile X-associated Tremor/Ataxia Syndrome

## Interventions

- **DRUG:** Allopregnanolone

## Key facts

- **NCT ID:** NCT02603926
- **Lead sponsor:** Randi J. Hagerman, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02603926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02603926, "Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02603926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*